01 1Boehringer Ingelheim Pharma GmbH and Co. KG
02 1Professional; Compounding Centers of America
01 2BUTYLSCOPOLAMINE BROMIDE
01 1Germany
02 1United Kingdom
NDC Package Code : 12714-011
Start Marketing Date : 2019-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0206
Start Marketing Date : 2000-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Hyoscine N-Butyl Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hyoscine N-Butyl Bromide, including repackagers and relabelers. The FDA regulates Hyoscine N-Butyl Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hyoscine N-Butyl Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hyoscine N-Butyl Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hyoscine N-Butyl Bromide supplier is an individual or a company that provides Hyoscine N-Butyl Bromide active pharmaceutical ingredient (API) or Hyoscine N-Butyl Bromide finished formulations upon request. The Hyoscine N-Butyl Bromide suppliers may include Hyoscine N-Butyl Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Hyoscine N-Butyl Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hyoscine N-Butyl Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hyoscine N-Butyl Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hyoscine N-Butyl Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hyoscine N-Butyl Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hyoscine N-Butyl Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hyoscine N-Butyl Bromide suppliers with NDC on PharmaCompass.
We have 2 companies offering Hyoscine N-Butyl Bromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
